Document is current
Any future updates will be listed below
-
Authors
Lai, Wenjian
Liao, Yuhua
Zhang, Huimin
Zhao, Hao
Li, Yanzi
Chen, Ruiying
Shi, Guangduoji
Liu, Yifen
Hao, Jiejing
Li, Zehui
Wang, Wanxin
McIntyre, Roger S.
Lu, Ciyong
Han, Xue
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82373660)
- License Information
-
More Information
Article History
Received: 13 November 2024
Accepted: 18 March 2025
First Online: 31 March 2025
Declarations
:
: This study received ethical approval from the institutional review board of School of Public Health, Sun Yat-sen University (L2017044) and the study protocol was approved by the Ethical Review Boards of all the participating centers. All participants provided informed consent. All personal information in the study data has been deidentified to protect the privacy of the participants.
: Not applicable.
: Roger S. McIntyre has received research grant support from CIHR/GACD/National Natural Science Foundation of China (NSFC) and the Milken Institute; speaker/consultation fees from Lundbeck, Janssen, Alkermes, Neumora Therapeutics, Boehringer Ingelheim, Sage, Biogen, Mitsubishi Tanabe, Purdue, Pfizer, Otsuka, Takeda, Neurocrine, Neurawell, Sunovion, Bausch Health, Axsome, Novo Nordisk, Kris, Sanofi, Eisai, Intra-Cellular, NewBridge Pharmaceuticals, Viatris, Abbvie and Atai Life Sciences. Dr. S. Roger McIntyre is a CEO of Braxia Scientific Corp.The other authors declare that they have no conflict of interest.
